Design Therapeutics (DSGN) director Lappe received 19,000 Stock Option (right to buy)
Stocks in this Quantisnow insightHealth Care
Insider transactions reported
Rodney W Lappe (director at Design Therapeutics Inc., DSGN) reported that they received 19,000 Stock Option (right to buy) on Jun 13, 2024.
- Reporting person
- Lappe Rodney W
Options and other derivatives
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Jun 13, 2024 | Grant or award (A) | Stock Option (right to buy)On 19,000 Common Stock1 | +19,000 | - | - | 19,000 direct |
Holdings before and after
- Stock Option (right to buy): 0 to 19,000 direct
Footnotes from the filing
- 1. The shares subject to the option vest in equal monthly installments over 12 months following June 13, 2024 provided that the shares subject to the option will in any case be fully vested on the date of the Company's next annual meeting of stockholders.
Transaction codes in this filing
- Grant or award:
- Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
FAQ
What did Lappe report in this DSGN Form 4?
Rodney W Lappe (director at Design Therapeutics Inc., DSGN) reported that they received 19,000 Stock Option (right to buy) on Jun 13, 2024.
What does transaction code A mean on an SEC Form 4?
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
Historical context for DSGN
Earlier insider filings at DSGN
- Jun 17, 2024SEC Form 4 filed by Director William Arsani
- Jun 17, 2024SEC Form 4 filed by Director Schmid John P.
- Jun 17, 2024SEC Form 4 filed by Director Berger Heather A.
- Mar 25, 2024Schmid John P. bought $99,738 worth of shares (26,965 units at $3.70) (SEC Form 4)
- Mar 25, 2024Berger Heather A. bought $4,866 worth of shares (1,300 units at $3.74) (SEC Form 4)
Quantisnow market dataNASDAQ
DSGN
Design Therapeutics Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2021
Get push alerts for DSGN
Full DSGN profile on Quantisnow Follow DSGN and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time